Serum neurofilament light and MRI predictors of cognitive decline in patients with secondary progressive multiple sclerosis: Analysis from the MS-STAT randomised controlled trial

Multiple secondary outcome analyses: precise interpretation is important

(2022) Richard A. Parker et al.   Trials

Assessing Neurofilaments as Biomarkers of Neuroprotection in Progressive Multiple Sclerosis

(2022) Thomas E. Williams et al.   Neurology-Neuroimmunology & Neuroinflammation

Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study

(2022) Pascal Benkert et al.   LANCET NEUROLOGY

Correlation Between Brain Structure Atrophy and Plasma Amyloid-β and Phosphorylated Tau in Patients With Alzheimer’s Disease and Amnestic Mild Cognitive Impairment Explored by Surface-Based Morphometry

(2022) Kaidi Li et al.   Frontiers in Aging Neuroscience

Validity of the Wechsler Abbreviated Scale of Intelligence, Second Edition (WASI-II) as an Indicator of Neurological Disease/Injury: A Pilot Study

(2021) Joseph J. Ryan et al.   BRAIN INJURY

Structural variation in the temporal lobe predicts learning and retention of non-native speech sounds

(2021) Pamela Fuhrmeister et al.   Language Cognition and Neuroscience

Cognitive Decline in Multiple Sclerosis Is Related to the Progression of Retinal Atrophy and Presence of Oligoclonal Bands: A 5-Year Follow-Up Study

(2021) Natasa Giedraitiene et al.   Frontiers in Neurology

Cortical Thickness and Serum NfL Explain Cognitive Dysfunction in Newly Diagnosed Patients With Multiple Sclerosis

(2021) Álvaro J. Cruz-Gomez et al.   Neurology-Neuroimmunology & Neuroinflammation

Optimal Surgical Extent for Memory and Seizure Outcome in Temporal Lobe Epilepsy

(2021) Daichi Sone et al.   ANNALS OF NEUROLOGY

Neurofilaments in progressive multiple sclerosis: a systematic review

(2020) Thomas Williams et al.   JOURNAL OF NEUROLOGY

Delay from treatment start to full effect of immunotherapies for multiple sclerosis

(2020) Izanne Roos et al.   BRAIN

Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues

(2020) Ralph H B Benedict et al.   LANCET NEUROLOGY

Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease

(2019) Oliver Preische et al.   NATURE MEDICINE

Blood neurofilament light chain as a biomarker of MS disease activity and treatment response

(2019) Jens Kuhle et al.   NEUROLOGY

Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis

(2019) Wallace J Brownlee et al.   BRAIN

Sex differences in gray matter volume: how many and how large are they really?

(2019) Carla Sanchis-Segura et al.   Biology of Sex Differences

Cortical atrophy accelerates as cognitive decline worsens in multiple sclerosis

(2019) Anand J.C. Eijlers et al.   NEUROLOGY

Serum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: A longitudinal retrospective 5-year study

(2019) Dejan Jakimovski et al.   Multiple Sclerosis Journal

Cognitive impairment in early stages of multiple sclerosis is associated with high cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain

(2018) E. Quintana et al.   EUROPEAN JOURNAL OF NEUROLOGY

Accelerated long-term forgetting in presymptomatic autosomal dominant Alzheimer's disease: a cross-sectional study

(2018) Philip S J Weston et al.   LANCET NEUROLOGY

Cognitive reserve, cognition, and regional brain damage in MS: A 2 -year longitudinal study

(2018) Maria Assunta Rocca et al.   Multiple Sclerosis Journal

Cognition in multiple sclerosis

(2018) James F. Sumowski et al.   NEUROLOGY

Cognitive reserve, cognition, and regional brain damage in MS: A 2 -year longitudinal study

(2018) Maria Assunta Rocca et al.   Multiple Sclerosis Journal

Differences in hippocampal subfield volume are seen in phenotypic variants of early onset Alzheimer's disease

(2018) Thomas D. Parker et al.   NeuroImage-Clinical

Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial

(2017) Dennis Chan et al.   LANCET NEUROLOGY

Serum neurofilament light in familial Alzheimer disease

(2017) Philip S.J. Weston et al.   NEUROLOGY

Monitoring disease activity in multiple sclerosis using serum neurofilament light protein

(2017) Lenka Novakova et al.   NEUROLOGY

Is multiple sclerosis a length-dependent central axonopathy? The case for therapeutic lag and the asynchronous progressive MS hypotheses

(2017) Gavin Giovannoni et al.   Multiple Sclerosis and Related Disorders

The patient’s perspective: How to create awareness for improving access to care and treatment of MS patients?

(2016) Patrick Vermersch et al.   Multiple Sclerosis Journal

Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia

(2016) Jonathan D. Rohrer et al.   NEUROLOGY

The patient’s perspective: How to create awareness for improving access to care and treatment of MS patients?

(2016) Patrick Vermersch et al.   Multiple Sclerosis Journal

Cognitive rehabilitation in multiple sclerosis: a randomized controlled trial

(2015) K. T. Hanssen et al.   ACTA NEUROLOGICA SCANDINAVICA

The grey matter correlates of impaired decision-making in multiple sclerosis

(2014) Nils Muhlert et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial

(2014) Jeremy Chataway et al.   LANCET

Cognitive and motor functioning in patients with multiple sclerosis: Neuropsychological predictors of walking speed and falls

(2012) Vanessa L. D'Orio et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES